|
Bianca Weinstock-Guttman
Bianca Weinstock-Guttman is an American neurologist. She is a SUNY Distinguished Professor at the University at Buffalo. Early life and educationWeinstock-Guttman completed her medical degree at the University of Bucharest in 1983 and her internship at Meir Hospital and Tel Aviv University.[1] CareerUpon completing her formal education, Weinstock-Guttman accepted a faculty position at University of Buffalo in 1998.[2] In 2006, she helped establish the Pediatric MS Center of Buffalo with a grant from the National Multiple Sclerosis Society.[2] In this role, she received the 2013 UB Exceptional Scholars Sustained Achievement Award.[3] In 2017, Weinstock-Guttman was named the principal investigator to lead clinical trials exploring potential therapeutic applications of cannabinoids in progressive multiple sclerosis.[4] The following year, she received the National Multiple Sclerosis Society's Impact Award for her research, patient care and advocacy skills.[5] During the COVID-19 pandemic, Weinstock-Guttman co-authored Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient with Dejan Jakimovski.[6] She was also the recipient of the 2020 Stockton Kimball Award for outstanding scientific achievement and service.[7] The following year, she was promoted to the rank of SUNY Distinguished Professor, the highest rank in the SUNY system.[8] References
External links
Information related to Bianca Weinstock-Guttman |
||||||||||||||
